Andreessen Horowitz is making a big move into biotech, and it’s using a $200 million new fund called the AH Bio Fund – and new general partner, Vijay Pande — to plant its stake in the ground. The fund will be used to invest in mostly early-stage startups at the intersection of computer science and […]
Scott Kupor
Why Andreessen Horowitz’s Fourth Fund is Likely Around the Corner
Yesterday, in a WSJ series on venture capitalists’ predictions for 2014, Managing Partner Scott Kupor of Andreessen Horowitz was asked if “venture capital returns have improved enough to draw renewed limited-partner interest in 2014.” Kupor said the question was really “whether investment dollars will continue to be concentrated in the top firms that enable them to generate […]